BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szabó E, Páska C, Kaposi Novák P, Schaff Z, Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004;10:5-11. [PMID: 15029254 DOI: 10.1007/BF02893401] [Cited by in Crossref: 66] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Yapali S, Lok AS. Should treatment of hepatitis B patients be based solely on liver fibrosis? Clin Gastroenterol Hepatol 2013;11:1500-2. [PMID: 23891926 DOI: 10.1016/j.cgh.2013.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Virzì A, Gonzalez-Motos V, Tripon S, Baumert TF, Lupberger J. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. J Clin Med 2021;10:977. [PMID: 33801181 DOI: 10.3390/jcm10050977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wu L, Tang Z, Li Y. Experimental models of hepatocellular carcinoma: developments and evolution. J Cancer Res Clin Oncol 2009;135:969-81. [DOI: 10.1007/s00432-009-0591-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
4 Testino G, Borro P. Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis. World J Hepatol 2013; 5(10): 521-527 [PMID: 24179611 DOI: 10.4254/wjh.v5.i10.521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Zakhary NI, Khodeer SM, Shafik HE, Abdel Malak CA. Impact of PIVKA-II in diagnosis of hepatocellular carcinoma. J Adv Res. 2013;4:539-546. [PMID: 25685463 DOI: 10.1016/j.jare.2012.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
6 Muccioli M, Longstaff C, Benencia F. Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma. Immunotherapy 2012;4:477-81. [PMID: 22642330 DOI: 10.2217/imt.12.39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Proulx J, Ghaly M, Park I, Borgmann K. HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers. Biomedicines 2022;10:768. [DOI: 10.3390/biomedicines10040768] [Reference Citation Analysis]
8 Lian M, Liu Y, Yu SZ, Qian GS, Wan SG, Dixon KR. Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice. World J Gastroenterol 2006; 12(19): 3065-3072 [PMID: 16718789 DOI: 10.3748/wjg.v12.i19.3065] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
9 Tsiambas E, Manaios L, Papanikolopoulos C, Rigopoulos DN, Tsounis D, Karameris A, Soultati A, Koliopoulou A, Kravvaritis C, Sergentanis T. Chromogenic in situ hybridization analysis of Epidermal Growth Factor Receptor gene/chromosome 7 numerical aberrations in hepatocellular carcinoma based on tissue microarrays. Pathol Oncol Res. 2009;15:511-520. [PMID: 19145479 DOI: 10.1007/s12253-008-9146-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
10 Volinsky I, Lombardo SD, Cheredman P. Stability Analysis and Cauchy Matrix of a Mathematical Model of Hepatitis B Virus with Control on Immune System near Neighborhood of Equilibrium Free Point. Symmetry 2021;13:166. [DOI: 10.3390/sym13020166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dorfman JD, Schulick R, Choti MA, Geschwind JFH, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol 2007; 13(5): 781-784 [PMID: 17278203 DOI: 10.3748/wjg.v13.i5.781] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li QY, Yang K, Liu FG, Sun XG, Chen L, Xiu H, Liu XS. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway. Clin Transl Oncol 2020;22:302-10. [PMID: 31625123 DOI: 10.1007/s12094-019-02223-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Wu SH, Cheng J, Zheng YJ, Zhang YX, Liu Y, Guo J, Zhang LY, Wang GQ. Screening and identification of target genes differentially expressed in HepG2 cells treated with arsenic trioxide by suppression subtractive hybridization technique. Shijie Huaren Xiaohua Zazhi 2005; 13(13): 1535-1539 [DOI: 10.11569/wcjd.v13.i13.1535] [Reference Citation Analysis]
14 Janevska D, Chaloska-Ivanova V, Janevski V. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Maced J Med Sci. 2015;3:732-736. [PMID: 27275318 DOI: 10.3889/oamjms.2015.111] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
15 Chen CC, Hsu HT, Chen YL, Chen RC, Wu WP, Chou CT. Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) and Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein (WFA⁺-M2BP) in Patients with Chronic Liver Disease. Med Sci Monit 2019;25:7169-74. [PMID: 31548540 DOI: 10.12659/MSM.916533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, Lee CM, Changchien CS, Wang JH. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int 2010;4:700-6. [PMID: 21286340 DOI: 10.1007/s12072-010-9223-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
17 Komura T, Mizukoshi E, Kita Y, Sakurai M, Takata Y, Arai K, Yamashita T, Ohta T, Shimizu K, Nakamoto Y, Honda M, Takamura T, Kaneko S. Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis. Am J Gastroenterol 2007;102:1939-46. [PMID: 17573788 DOI: 10.1111/j.1572-0241.2007.01354.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
18 Yoo J, Hann HW, Coben R, Conn M, DiMarino AJ. Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure. Diseases. 2018;6:E27. [PMID: 29677098 DOI: 10.3390/diseases6020027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
19 Ariyasu T, Tanaka T, Fujioka N, Yanai Y, Yamamoto S, Yamauchi H, Ikegami H, Ikeda M, Kurimoto M. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell Dev Biol Anim. 2005;41:50-56. [PMID: 15926860 DOI: 10.1290/0501008.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
20 Derbala M, Amer A. Hepatocellular carcinoma in Hepatitis C genotype 4 after viral clearance and in absence of cirrhosis: two case reports. Cases J 2009;2:7927. [PMID: 20181199 DOI: 10.1186/1757-1626-0002-0000007927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Zakhary NI, El-merzabani MM, El-sawi NM, Saleh SM, Moneer MM, Mohamad RH. Impact of different biochemical markers in serum of patients with benign and malignant liver diseases. Journal of Advanced Research 2011;2:49-55. [DOI: 10.1016/j.jare.2010.08.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Benencia F, Sprague L, McGinty J, Pate M, Muccioli M. Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. J Biomed Biotechnol. 2012;2012:425476. [PMID: 22505809 DOI: 10.1155/2012/425476] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
23 El-Zayadi AR, Badran HM, Barakat EM, Attia MED, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: A single center study over a decade. World J Gastroenterol 2005; 11(33): 5193-5198 [PMID: 16127751 DOI: 10.3748/wjg.v11.i33.5193] [Cited by in F6Publishing: 42] [Reference Citation Analysis]
24 Sami H, Rizvi M, Azam M, Mukherjee RM, Shukla I, Ajmal MR, Malik A. Emergence of hepatitis B virus genotype f in aligarh region of north India. Adv Virol 2013;2013:846849. [PMID: 24381592 DOI: 10.1155/2013/846849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
25 Leite ST, Silva MB, Pepato MA, Souto FJ, Santos RA, Bassi-Branco CL. Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus. Mem Inst Oswaldo Cruz 2014;109:15-20. [PMID: 24626305 DOI: 10.1590/0074-0276140183] [Reference Citation Analysis]
26 Abd-Elsalam S, Elwan N, Soliman H, Ziada D, Elkhalawany W, Salama M, Hawash N, Arafa M, Badawi R, Shehata WM, Khalil HS, Elmashad N. Epidemiology of liver cancer in Nile delta over a decade: A single-center study. South Asian J Cancer 2018;7:24-6. [PMID: 29600229 DOI: 10.4103/sajc.sajc_82_17] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
27 Benencia F, Muccioli M, Alnaeeli M. Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies. Front Oncol 2014;4:72. [PMID: 24778991 DOI: 10.3389/fonc.2014.00072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
28 Abd El Moety HA, Maharem DA, Gomaa SH. Serotonin: is it a marker for the diagnosis of hepatocellular carcinoma in cirrhotic patients? Alexandria Journal of Medicine 2013;49:369-78. [DOI: 10.1016/j.ajme.2013.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Liu SF, Hsieh MH, Hou NJ, Hsieh MY, Huang JF, Dai CY, Yu ML, Chuang WL. Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan. Hepatol Int 2010;4:601-7. [PMID: 21063483 DOI: 10.1007/s12072-010-9198-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
30 Hassany SM, Moustafa EFA, Taher ME, Abdeltwab AA, Blum HE. Screening for hepatocellular carcinoma by Egyptian physicians. World J Gastrointest Oncol 2015; 7(9): 161-171 [PMID: 26380060 DOI: 10.4251/wjgo.v7.i9.161] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Macdonald DC, Nelson M, Bower M, Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol 2008; 14(11): 1657-1663 [PMID: 18350596 DOI: 10.3748/wjg.14.1657] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]